Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Epilepsia|July 2, 2019
Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsyRobert T Wechsler, Rodney A Radtke, Michael Smith, et al.
The Journal of Infectious Diseases|August 6, 2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.
Epilepsy & Behavior : E&B|June 3, 2017
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trialsVictor Biton, Joanne B Rogin, Gregory Krauss, et al.
Epilepsy & Behavior : E&B|April 1, 2018
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizuresEva Andermann, Victor Biton, Selim R Benbadis, et al.
Epilepsia|December 23, 2014
Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trialMichael R Sperling, Bassel Abou-Khalil, Jay Harvey, et al.
The Journal of Infectious Diseases|August 27, 2002
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359Roy M Gulick, X Joan Hu, Susan A Fiscus, et al.
Pageof 3